Long-term function of human cardiac allografts assessed by two-dimensional echocardiography

J Thorac Cardiovasc Surg. 1989 Aug;98(2):275-84.

Abstract

Previous studies from our laboratory demonstrated increasing left ventricular mass in cyclosporine-treated cardiac allograft recipients over 30 days after transplantation, but the long-term evolution of this process and possible effects on allograft function are unknown. Accordingly, quantitative two-dimensional echocardiography was performed 2 and 23 days and 15 months postoperatively in 14 recipients treated with cyclosporine and prednisone. Changes in left ventricular ejection fraction, end-diastolic volume, mass, and end-systolic wall stress were analyzed. Comparison of studies at 2 and 23 days revealed significant (p less than 0.01) increases in ejection fraction (54% +/- 8% [standard deviation] to 62% +/- 4%), end-diastolic volume (84% +/- 32 ml to 96 +/- 31 ml), and left ventricular mass (118 +/- 45 gm to 136 +/- 41 gm). Comparison of studies at 23 days and 15 months revealed no significant change in end-diastolic volume or left ventricular mass, whereas ejection fraction decreased slightly (62% +/- 4% to 57% +/- 4%, p less than 0.01). End-systolic wall stress decreased when data at 2 days and 15 months were compared (83 +/- 24 gm/cm2 versus 66 +/- 18 gm/cm2, p less than 0.05), but no change in contractility was apparent from the ejection fraction/end-systolic stress relation. We conclude that left ventricular mass and end-diastolic volume increase early after transplantation in cyclosporine-treated cardiac allograft recipients, but these changes are not predictive of long-term results, which are characterized by no significant late variation in left ventricular mass, end-diastolic volume, or contractility.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Biopsy
  • Blood Pressure
  • Cardiomegaly / chemically induced
  • Cardiomegaly / physiopathology
  • Child
  • Child, Preschool
  • Cyclosporins / adverse effects
  • Cyclosporins / therapeutic use
  • Echocardiography*
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Heart Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Myocardium / pathology
  • Prednisone / therapeutic use
  • Stroke Volume

Substances

  • Cyclosporins
  • Prednisone